•
Dec 31, 2018

Edwards Lifesciences Q4 2018 Earnings Report

Total Revenue
$978M
Previous year: $889M
+10.0%
EPS
$0.39
Previous year: $0.31
+25.8%
Gross Profit Margin
76%
SG&A Expenses
$288M
R&D Expenses
$163M
Gross Profit
$743M
Previous year: $653M
+13.7%
Cash and Equivalents
$714M
Previous year: $818M
-12.7%
Free Cash Flow
$235M
Previous year: $312M
-24.6%
Total Assets
$5.32B
Previous year: $5.67B
-6.0%

Edwards Lifesciences

Edwards Lifesciences

Edwards Lifesciences Revenue by Segment

Edwards Lifesciences Revenue by Geographic Location

Revenue & Expenses

Visualization of income flow from segment revenue to net income